RU2017111848A3 - - Google Patents

Download PDF

Info

Publication number
RU2017111848A3
RU2017111848A3 RU2017111848A RU2017111848A RU2017111848A3 RU 2017111848 A3 RU2017111848 A3 RU 2017111848A3 RU 2017111848 A RU2017111848 A RU 2017111848A RU 2017111848 A RU2017111848 A RU 2017111848A RU 2017111848 A3 RU2017111848 A3 RU 2017111848A3
Authority
RU
Russia
Application number
RU2017111848A
Other languages
Russian (ru)
Other versions
RU2738886C2 (ru
RU2017111848A (ru
RU2738886C9 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017111848A publication Critical patent/RU2017111848A/ru
Publication of RU2017111848A3 publication Critical patent/RU2017111848A3/ru
Publication of RU2738886C2 publication Critical patent/RU2738886C2/ru
Application granted granted Critical
Publication of RU2738886C9 publication Critical patent/RU2738886C9/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2017111848A 2014-09-09 2015-09-09 Новая фармацевтическая композиция для профилактики и/или лечения недержания мочи RU2738886C9 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014-183434 2014-09-09
JP2014183434 2014-09-09
PCT/JP2015/075567 WO2016039367A1 (fr) 2014-09-09 2015-09-09 Nouvelle composition pharmaceutique pour la prévention et/ou le traitement de l'incontinence urinaire

Publications (4)

Publication Number Publication Date
RU2017111848A RU2017111848A (ru) 2018-10-08
RU2017111848A3 true RU2017111848A3 (fr) 2019-07-17
RU2738886C2 RU2738886C2 (ru) 2020-12-18
RU2738886C9 RU2738886C9 (ru) 2021-12-06

Family

ID=55459111

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017111848A RU2738886C9 (ru) 2014-09-09 2015-09-09 Новая фармацевтическая композиция для профилактики и/или лечения недержания мочи

Country Status (18)

Country Link
US (1) US9987279B2 (fr)
EP (1) EP3192512B1 (fr)
JP (1) JP6573618B2 (fr)
KR (1) KR102460731B1 (fr)
CN (1) CN106687115B (fr)
AU (1) AU2015313221B2 (fr)
BR (1) BR112017004505A2 (fr)
CA (1) CA2957804C (fr)
ES (1) ES2750751T3 (fr)
IL (1) IL250919B (fr)
MX (1) MX2017002853A (fr)
PH (1) PH12017500436A1 (fr)
PL (1) PL3192512T3 (fr)
PT (1) PT3192512T (fr)
RU (1) RU2738886C9 (fr)
SG (1) SG11201701019UA (fr)
WO (1) WO2016039367A1 (fr)
ZA (1) ZA201701671B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
SI3413892T1 (sl) 2016-02-12 2022-06-30 Cytokinetics, Incorporated Tetrahidroizokinolinski derivati
BR112020013020A2 (pt) 2017-12-26 2020-11-24 Cytokinetics, Incorporated métodos para preparar compostos ,e, compostos
AU2021373814A1 (en) 2020-11-06 2023-05-25 Cytokinetics, Inc. Bicyclic 1,4-diazepanones and therapeutic uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1725540E (pt) 2004-03-05 2012-11-29 Hoffmann La Roche Diaminopirimidinas como antagonistas de p2x3 e p2x2/3
EP1879578A4 (fr) * 2005-03-21 2009-05-13 Dov Pharmaceutical Inc Methodes et compositions destinees au traitement de l'incontinence urinaire
JP2007176933A (ja) * 2005-11-29 2007-07-12 Tanabe Seiyaku Co Ltd 医薬組成物
JP2007290970A (ja) * 2006-04-21 2007-11-08 Astellas Pharma Inc 腹圧性及び混合型尿失禁治療剤
CA2672591A1 (fr) 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. Agent therapeutique de l'uropathie
EP2216021B1 (fr) * 2007-11-02 2012-10-17 Astellas Pharma Inc. Composition pharmaceutique pour traiter une vessie hyperactive
JP5553547B2 (ja) 2009-07-14 2014-07-16 俊一 梶岡 トロポニン含有医薬組成物
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
CA2868507A1 (fr) * 2012-04-02 2013-10-10 Cytokinetics, Inc. Procedes d'amelioration de la fonction de diaphragme
JP6352244B2 (ja) * 2012-04-11 2018-07-04 サイトキネティックス, インコーポレイテッド 骨格筋疲労に対する耐性を向上させるための方法

Also Published As

Publication number Publication date
EP3192512A1 (fr) 2017-07-19
AU2015313221B2 (en) 2019-11-21
JPWO2016039367A1 (ja) 2017-06-15
AU2015313221A1 (en) 2017-03-09
PT3192512T (pt) 2019-10-29
ES2750751T3 (es) 2020-03-27
CA2957804C (fr) 2023-04-04
MX2017002853A (es) 2018-01-12
CN106687115B (zh) 2019-07-19
EP3192512A4 (fr) 2018-02-07
PL3192512T3 (pl) 2020-03-31
CA2957804A1 (fr) 2016-03-17
SG11201701019UA (en) 2017-03-30
US9987279B2 (en) 2018-06-05
EP3192512B1 (fr) 2019-08-14
IL250919B (en) 2019-10-31
ZA201701671B (en) 2019-06-26
KR20170045353A (ko) 2017-04-26
BR112017004505A2 (pt) 2018-01-23
US20170273979A1 (en) 2017-09-28
JP6573618B2 (ja) 2019-09-11
KR102460731B1 (ko) 2022-10-28
WO2016039367A1 (fr) 2016-03-17
CN106687115A (zh) 2017-05-17
RU2738886C2 (ru) 2020-12-18
PH12017500436A1 (en) 2017-07-31
IL250919A0 (en) 2017-04-30
RU2017111848A (ru) 2018-10-08
RU2738886C9 (ru) 2021-12-06

Similar Documents

Publication Publication Date Title
BR112016025875A2 (fr)
BR112016026285A2 (fr)
BR112016013761A2 (fr)
BR112016027500A2 (fr)
BR112016026714A2 (fr)
BR112016027656A2 (fr)
BR112016026000A2 (fr)
BR112016025892A2 (fr)
BR112016021545A2 (fr)
BR112016030745A2 (fr)
BR112016030921A2 (fr)
BR112016026720A2 (fr)
BR112016030861A2 (fr)
RU2017108178A3 (fr)
BR112016027829A2 (fr)
BR112016026440A2 (fr)
BR112016026913A2 (fr)
JP1527066S (fr)
JP1522118S (fr)
JP1516163S (fr)
BR112016017419A2 (fr)
BR122021021291A2 (fr)
CN302710865S (fr)
CN302866626S (fr)
CN302858335S (fr)

Legal Events

Date Code Title Description
TH4A Reissue of patent specification
TK49 Information related to patent modified

Free format text: CORRECTION TO CHAPTER -FG4A- IN JOURNAL 35-2020 FOR INID CODE(S) (54)